A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?

被引:4
作者
Shafiee, Arman [1 ,2 ]
Teymouri Athar, Mohammad Mobin [3 ]
Mozhgani, Sayed-Hamidreza [4 ,5 ]
机构
[1] Alborz Univ Med Sci, Clin Res Dev Unit, Karaj, Iran
[2] Alborz Univ Med Sci, Student Res Comm, Sch Med, Karaj, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran
[4] Alborz Univ Med Sci, Sch Med, Dept Microbiol, Karaj, Iran
[5] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran
关键词
antiviral; COVID-19; evidence-based medicine; ivermectin; misinformation; social media;
D O I
10.2217/fvl-2023-0006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This editorial examines what has caused the evidence around ivermectin to be so controversial, provides a brief analysis of recently published evidence, and highlights why it is important to learn lessons from ivermectin for future re-purposed drugs.
引用
收藏
页码:137 / 139
页数:3
相关论文
共 20 条
[1]  
Bramante CT, 2022, NEW ENGL J MED, V387, P599, DOI 10.1056/NEJMoa2201662
[2]   The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [J].
Caly, Leon ;
Druce, Julian D. ;
Catton, Mike G. ;
Jans, David A. ;
Wagstaff, Kylie M. .
ANTIVIRAL RESEARCH, 2020, 178
[3]   Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic [J].
Castillejos-Lopez, Manuel ;
Torres-Espindola, Luz Maria ;
Huerta-Cruz, Juan Carlos ;
Flores-Soto, Edgar ;
Romero-Martinez, Bianca S. ;
Velazquez-Cruz, Rafael ;
Higuera-Iglesias, Anjarath ;
Camarena, Angel ;
Torres-Soria, Ana Karen ;
Salinas-Lara, Citlaltepetl ;
Fernandez-Plata, Rosario ;
Alvarado-Vasquez, Noe ;
Solis-Chagoyan, Hector ;
Ruiz, Victor ;
Aquino-Galvez, Arnoldo .
LIFE-BASEL, 2022, 12 (09)
[4]  
Chaudhry MW., 2021, ADV RESPIR MED, V89
[5]   Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach [J].
Choudhury, Abhigyan ;
Das, Nabarun C. ;
Patra, Ritwik ;
Bhattacharya, Manojit ;
Ghosh, Pratik ;
Patra, Bidhan C. ;
Mukherjee, Suprabhat .
FUTURE VIROLOGY, 2021, 16 (04) :277-291
[6]  
Deng J., 2022, QJM MON J ASS PHYS, V115
[7]  
Garegnani LI., 2022, BMJ EVID-BASED MED, V27
[8]  
Hill A., 2022, J ANTIMICROB CHEMOTH, V77
[9]  
Hua Y., 2022, J AM MED INFORM ASSN, V29
[10]   Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results [J].
Izcovich, Ariel ;
Peiris, Sasha ;
Ragusa, Martin ;
Tortosa, Fernando ;
Rada, Gabriel ;
Aldighieri, Sylvain ;
Reveiz, Ludovic .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 144 :43-55